Research Article
A Single-Center 18-Year Series of 73 Cases of Metaplastic Carcinoma of the Breast
Table 3
Survival analyses, overall survival (OS).
| | Survival (%) | |
| 5-year OS rate | 66.8 | — | Pathological T | | <0.0001 | pT0-1 | 82.4 | | pT2 | 71.5 | pT3-4 | 20.0 | Pathological N | | 0.049 | pN0 | 73.5 | | pN+ | 42.9 | Chemotherapy | | 0.003 | Yes | 73.5 | | No | 50.2 | Chemotherapy type | | 0.001 | Adjuvant | 82.8 | | Neoadjuvant | 25.0 | Radiotherapy | | 0.107 | Yes | 72.4 | | No | 51.3 | Surgery type | | <0.0001 | Mastectomy | 43.5 | | Breast-conserving surgery | 90.3 | Pathological subtype | | 0.423 | Adenosquamous, low-grade | 100 | | Fibromatosis-like | 100 | Spindle cell | 67.5 | Squamous cell | 58.7 | Heterologous mesenchymal cell differentiation | 83.3 | Mixed | 53.9 | Pathological subtype, grouped | | 0.094 | Nonmixed | 73.4 | | Mixed | 53.9 |
|
|